HP
28
3
DTE
45
3
DAL
51
7
TJX
53
3
HPE
61
4
APD
49
4
NWSA
82
6
FOX
57
2
AIG
74
8
AXP
69
3
SEE
34
4
MMM
63
4
INTC
27
4
USB
66
12
L
63
3
LUV
56
4
JBHT
26
6
MU
62
2
XOM
48
6
HD
52
2
HP
28
3
DTE
45
3
DAL
51
7
TJX
53
3
HPE
61
4
APD
49
4
NWSA
82
6
FOX
57
2
AIG
74
8
AXP
69
3
SEE
34
4
MMM
63
4
INTC
27
4
USB
66
12
L
63
3
LUV
56
4
JBHT
26
6
MU
62
2
XOM
48
6
HD
52
2
Financhill
Back

Takeda Pharmaceutical 10K Form

Sell
25

TKPHF
Takeda Pharmaceutical

Last Price:
$29.85
Seasonality Move:
-0.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TKPHF News And Ratings

See the #1 stock for the next 7 days that we like better than TKPHF

TKPHF Financial Statistics

Sales & Book Value

Annual Sales: $29.5B
Cash Flow: $2.1B
Price / Cash Flow: 9.39
Annual Sales: $29.80
Price / Book: 1

Profitability

EPS (TTM): 0.85140
Net Income (TTM): $1.4B
Gross Margin: $19.7B
Return on Equity: 2.85%
Return on Assets: 1.37%

Takeda Pharmaceutical Earnings Forecast

Key Takeda Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 25 years for TKPHF is 66.54%.
  • The Selling, General & Administrative Expenses for TKPHF have been equal to 24.72% of Gross Profit Margin.
  • The Research & Development expenses have been 17.12% of Revenue.
  • The Interest Expense is 82.97% of Operating Income.
  • The Net Earning history of TKPHF is 3.38% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 15 years.

Takeda Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TKPHF
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.65
Current Ratio: 1.31
Quick Ratio: 0.6

Price-to-Earnings

Trailing P/E Ratio: 47.25
Forward P/E Ratio: 0

TKPHF Technical Analysis vs Fundamental Analysis

Sell
25
Takeda Pharmaceutical (TKPHF) is a Sell

Is Takeda Pharmaceutical a Buy or a Sell?